Medical News

RSS

Lab made urinary tube going strong after six years of transplant

In a scientific breakthrough, five boys who were unable to urinate due to pelvic injury were cured for up to six years after getting new lab-grown urethras or urinary tubes that connect with the bladder. This breakthrough comes from Wake Forest University researcher Anthony Atala. It was in 2006 that the team reported the first successful implantation of lab-grown urinary bladders into humans. Today six years after the operation all of the boys continue to do well, with normal or near-normal urinary flow. The boy first treated is now 16 years old and received his lab-grown urethra over six years ago.

8 Mar 2011

EHR? Not so fast - Patients express security concerns

CDW Healthcare, part of the public sector subsidiary of CDW LLC, today announced the results of a national survey on patient perceptions of electronic health records (EHRs) and the security of personal health information (PHI). The report, “Elevated Heart Rates: EHR and IT Security,” found that while patients trust their doctors to protect their information, 49 percent believe that EHRs will have a negative impact on the privacy of their PHI and health data.

8 Mar 2011

Single-wall carbon nanotubes targeted and killed cancer cells without harming the healthy cells

SouthWest NanoTechnologies’ (SWeNT) Single-Wall Carbon Nanotubes (SWCNT) exhibit promising potential for use in biomedical treatments such as cancer photo thermal therapies, new research reveals.

8 Mar 2011

On-call physician compensation survey released

Sullivan, Cotter and Associates, Inc. has published its sixth annual survey of physician on-call pay rates and practices, the 2010 Physician On-call Pay Survey Report. The survey report, with data from 148 health care organizations nationwide, outlines physician on-call pay practices and rates paid for 40 physician specialty areas along with data reported for trauma centers and non-trauma centers.

8 Mar 2011

Study analyzes role of PARP enzyme in eukaryotes

An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.

8 Mar 2011

Patrys succeeds in obtaining commercial yields for its anti-cancer antibody therapeutic

Patrys Limited (ASX: PAB), which is developing a new class of antibody molecules for the treatment of cancer, is pleased to announce success in obtaining commercial production yields for natural human antibody PAT-SC1, facilitating the advancement of this promising product toward a second human clinical trial for the treatment of cancer.

8 Mar 2011

$100 million in grants for medical research announced

More than $100 million in grants was announced this Tuesday for an ambitious research project that will try to find what makes cancer so hard to beat. This project received $21.3 million from the National Health and Medical Research Council grants.

8 Mar 2011

Conflicts in medical management of hemophilia

Hemophilia is a medical disorder that is part of our genetic load as humans. It will never disappear. Therefore, the only way to live with it is to receive adequate medical management. Its effects on those males who have inherited the disorder that affects their blood clotting without treatment includes recurrent hemorrhages (bleeds) into joints as well as internal bleeding. The bleeds are painful, resulting in disuse, disability and crippling. The first signs usually appear in early childhood. A child who suffers a mouth bleed can slowly lose enough blood to result in death.

8 Mar 2011

Henry Schein MicroMD EMR Version 7.5 attains ONC-ATCB Complete EHR certification status

Henry Schein MicroMD, a provider of proven and cost-effective practice management and electronic medical records systems, announced today that its MicroMD EMR Version 7.5 achieved ONC-ATCB 2011/2012 Complete EHR Certification, and can help health care providers using Electronic Health Record technology meet the requirements needed to receive financial incentives earmarked under President Obama's American Recovery and Reinvestment Act of 2009.

8 Mar 2011

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.

8 Mar 2011

First Edition: March 8, 2011

In today's headlines, news about ongoing budget discussions and how issues like Medicare spending and the health law fit into them as well as reports about the growing interest in replacing the current chief of the Centers for Medicare and Medicaid Services.

8 Mar 2011

CNIT fourth quarter revenues increase 94.1% to US$61.22 million

Information Technology, Inc., a leading total solutions provider of geographic information systems, digital public security technology and digital hospital information systems in China, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2010.

8 Mar 2011

New insight into malaria

A group of researchers from EPFL's Global Health Institute and Inserm has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria.

8 Mar 2011

Nursing professors to develop new device for older adults

For those of us living the frenetic modern lifestyle, sitting in one place for a long period might seem like a vacation. But for those who are retired, it can lead to health complications.

8 Mar 2011

Compugen reports positive results from CGEN-25068 in animal model to treat certain disease conditions

Compugen Ltd. announced today positive animal model results for CGEN-25068, a novel peptide predicted and selected in silico to block a specific protein-protein interaction known to play an important role in various immune-related disease conditions.

8 Mar 2011

New discovery in childhood respiratory disease

Researchers have identified a critical part of the process by which one of the world's most common and dangerous early childhood infections, respiratory syncytial virus, causes disease.

8 Mar 2011

Kellogg partners with Action for Healthy Kids to launch Share Your Breakfast program

Breakfast is the most important meal of the day, yet the alarming reality is that 1 in 4 children live in homes where food is not always available, sometimes making breakfast hard to come by. As a breakfast leader, Kellogg has partnered with Action for Healthy Kids to launch the Share Your Breakfast program to encourage Americans to help children who might otherwise go without.

8 Mar 2011

BMY to present new Phase II data on investigational hepatitis C compounds at ILC

New Phase II data on multiple Bristol-Myers Squibb Company investigational hepatitis C compounds will be presented at The International Liver Congress, the 46th annual meeting of the European Association for the Study of the Liver in Berlin, Germany, from March 30 to April 2.

8 Mar 2011

Vertos reports long-term safety and efficacy of mild in patients with LSS

Medical device company Vertos Medical Inc. has announced the release of clinical study data demonstrating the long-term safety and efficacy of mild as well as its superior durability over epidural steroid injections for treating lumbar spinal stenosis.

8 Mar 2011

Neoprobe reports positive feedback from FDA for RIGScan development

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has completed a successful pre-IND meeting with the U.S. Food and Drug Administration on the development of RIGScan CR, the Company's proprietary radiopharmaceutical for the detection of colorectal cancer tumors.

8 Mar 2011

Medical News

Lab made urinary tube going strong after six years of transplant

EHR? Not so fast - Patients express security concerns

Single-wall carbon nanotubes targeted and killed cancer cells without harming the healthy cells

On-call physician compensation survey released

Study analyzes role of PARP enzyme in eukaryotes

Patrys succeeds in obtaining commercial yields for its anti-cancer antibody therapeutic

$100 million in grants for medical research announced

Conflicts in medical management of hemophilia

Henry Schein MicroMD EMR Version 7.5 attains ONC-ATCB Complete EHR certification status

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

First Edition: March 8, 2011

CNIT fourth quarter revenues increase 94.1% to US$61.22 million

New insight into malaria

Nursing professors to develop new device for older adults

Compugen reports positive results from CGEN-25068 in animal model to treat certain disease conditions

New discovery in childhood respiratory disease

Kellogg partners with Action for Healthy Kids to launch Share Your Breakfast program

BMY to present new Phase II data on investigational hepatitis C compounds at ILC

Vertos reports long-term safety and efficacy of mild in patients with LSS

Neoprobe reports positive feedback from FDA for RIGScan development

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News